Overview
This interview, recorded in 2006 for AutismOne Radio, features KP Stoller, MD, who discusses the scientific foundations, clinical applications, and political barriers surrounding hyperbaric oxygen therapy (HBOT), autism treatment, vaccine safety, and food‑industry toxins.
Hyperbaric Oxygen Therapy and Mitochondrial Biogenesis
Dr. Stoller outlines HBOT’s origins and explains how increased oxygen pressure stimulates mitochondrial biogenesis—an essential process for neurological repair. He describes how HBOT improves cerebral blood flow, reduces neuroinflammation, and supports recovery in brain‑injured and autistic patients.
He also reviews the technical aspects of HBOT, including pressure selection, oxygen dosing, and the role of SPECT scans in assessing cerebral perfusion before and after treatment. According to Dr. Stoller, individualized protocols are critical for maximizing therapeutic benefit.
Biomedical Approaches to Autism
Dr. Stoller emphasizes that treating autism requires a comprehensive biomedical strategy that includes detoxification, metabolic support, and targeted therapies like HBOT. He discusses how oxidative stress, impaired mitochondrial function, and environmental toxins intersect to shape autism pathology.
Thimerosal and the Vaccine Controversy
A major portion of the interview focuses on the political and scientific conflict surrounding thimerosal, the mercury‑based vaccine preservative. Dr. Stoller argues that federal health agencies, influenced by pharmaceutical interests, disregarded early warnings and downplayed risks. He characterizes the ongoing exposure of children to mercury‑containing vaccines as a preventable public‑health catastrophe.
Aspartame, Neurotoxicity, and Regulatory Failure
Dr. Stoller further explores the approval history of aspartame, noting that the compound had once been examined as a potential chemical‑warfare agent. He asserts that its wide adoption resulted from corporate influence rather than scientific merit, calling it a neurotoxic, cancer‑linked molecule embedded into the food supply through regulatory misconduct.
Conclusion
The interview portrays a medical landscape where scientific evidence, patient care, and public health are frequently overshadowed by political and corporate power. Dr. Stoller urges listeners to understand these dynamics, advocate for regulatory reform, and pursue biomedical interventions—such as HBOT—that hold promise for neurodevelopmental recovery.
Source: Interview with Dr. Kenneth P. Stoller: Hyperbaric oxygen therapy (HBOT),
Autism, Aspartame and Mercury | K.P. Stoller and T. Small/Medical Veritas 3 (2006) 957–966
